1. APA (1997) Practice guideline for the treatment of patients with schizophrenia. APA, Washington
2. Awad AG (1992) Quality of life of schizophrenic patients on medications and implications for new drug trials. Hosp Community Psychiatry 43: 262–265
3. Awad AG (1994) Prediction research of neuroleptic treatment outcome in schizophrenia - State of the art: 1978–1993. In: Gaebel W, Awad AG (eds) Prediction of neuroleptic treatment outcome in schizophrenia - concepts and methods. Springer, Wien, pp 1–14
4. Bachrach LL (1992) Case manage-ment revisited. Hosp Community Psychiatry 43: 209–210
5. Barnes TRE, Milavic G, Curson DA, Piatt SD (1983) Use of the social behaviour assessment schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine. Soc Psychiatry 18: 193–199